Bare Anatomy is a Gurugram-based Indian personalised haircare and skincare brand, and a brand of parent company Innovist (formerly Onesto Labs); figures below for revenue and funding are the parent's.
This Startup Deep Dive explains what Bare Anatomy does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.
Bare Anatomy in Brief
- What it is: Bare Anatomy is an Indian Personalised haircare and skincare (D2C) company based in Gurugram.
- Who it serves: online shoppers, retail customers, marketplaces and distribution partners.
- Sells personalised, made-to-order hair and skin products online, based on a quiz that converts answers into custom formulas.
- Haircare range includes pre-shampoo mask, shampoo and conditioner; skincare has a few products.
- Parent Innovist also owns Chemist at Play, SunScoop and Vinci Botanicals.
- Funding: Over $16 million at Innovist level (before Series B reports differ).
Bare Anatomy Quick Facts
| Company | Bare Anatomy |
| Founded | 2018 |
| Headquarters | Gurugram |
| Founders | Rohit Chawla, Sifat Khurana, Vimal Bhola |
| Sector | Personalised haircare and skincare (D2C) |
| Total funding | Over $16 million at Innovist level (before Series B reports differ) |
| Latest round | Innovist Series B of Rs 136 crore (about $15.8 million) led by ICICI Venture's IVen Amplifi fund |
| Valuation | Not disclosed; one early report estimated about $140 million post-money |
| Website | Not disclosed |
Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.
What Is Bare Anatomy?
Bare Anatomy operates in the Personalised haircare and skincare (D2C) space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Bare Anatomy.
- Sells personalised, made-to-order hair and skin products online, based on a quiz that converts answers into custom formulas.
- Haircare range includes pre-shampoo mask, shampoo and conditioner; skincare has a few products.
- Parent Innovist also owns Chemist at Play, SunScoop and Vinci Botanicals.
- Manufactures in-house at a Gurugram facility per one source.
The Origin Story of Bare Anatomy
Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.
- Founders: Rohit Chawla, Sifat Khurana, Vimal Bhola.
- Rohit Chawla conceptualised the brand in 2018 with co-founders Sifat Khurana and Vimal Bhola; sources differ on 2018 versus 2019 for founding/launch.
- Launched as an online-only brand, focused on personalisation and a scientific approach.
- Seed funding of $500,000 came from Sauce.vc.
Key Milestones and Challenges
No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Personalised haircare and skincare (D2C) sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.
- 2018-2019: brand conceived and launched.
- 2021: raised $2.5 million.
- Pre-Series A: $3.5 million led by Accel and 72 Ventures.
- Series A: about $7 million led by Amazon Smbhav Venture Fund.
- FY25: Innovist operating revenue about Rs 299 crore, up from Rs 105.8 crore.
- 2025: Series B of Rs 136 crore led by ICICI Venture.
Bare Anatomy Funding and Investors
Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.
- Seed: $500,000 from Sauce.vc.
- 2021: $2.5 million.
- Pre-Series A: $3.5 million led by Accel Partners and 72 Ventures.
- Series A: about $7 million led by Amazon Smbhav Venture Fund with 72 Ventures, Accel India and Sauce.vc.
- Series B: Rs 136 crore (about $15.8 million), primary and secondary, led by ICICI Venture's IVen Amplifi with Mirabilis Investment Trust, Niveshaay and Sauce.vc; Accel exited via secondary.
How Does Bare Anatomy Make Money? (Business Model)
A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to online shoppers, retail customers, marketplaces and distribution partners, sales cycles and contract size matter as much as headline growth.
- Direct-to-consumer online sales through its own website and digital marketing.
- Made-to-order production after each order, with quiz data retained for repeat personalised orders.
- Multi-brand portfolio at parent level.
The Numbers: Bare Anatomy Financials
Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.
- Innovist (parent) FY24: operating revenue about Rs 105.8 crore, loss about Rs 12.5 crore.
- Innovist FY25: operating revenue about Rs 299 crore (company says over Rs 300 crore), profit about Rs 12 crore helped by Rs 11.8 crore deferred tax income; EBITDA about Rs 1 crore (0.42% margin).
- Older aggregator data for FY23 is inconsistent (revenue about Rs 36.5-39.4 crore, loss about Rs 16.6-16.9 crore).
Market Opportunity for Bare Anatomy
Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising internet and smartphone use, growing online retail, digital payments, quick commerce and a younger consumer base that is open to new brands. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.
- Indian digital-first haircare and skincare, with many online brands now competing in the same space.
Technology and Product at Bare Anatomy
Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are supply-chain reliability, brand trust, product quality, data on customer behaviour and the efficiency of fulfilment.
- Proprietary quiz and algorithms generating personalised formulas, with custom hardware to dispense ingredients; built in-house, machine learning planned.
Team and Culture at Bare Anatomy
Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.
- Rohit Chawla is CEO.
- Co-founders Sifat Khurana and Vimal Bhola.
Bare Anatomy Competitors: Competitive Landscape
A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.
| Competitor | How it differs |
|---|---|
| Mamaearth | Named as competitor in coverage of Innovist funding. |
| Minimalist | Named as competitor in coverage of Innovist funding. |
| Desi Farms | Named as competitor in coverage of Innovist funding. |
Risks and Challenges for Bare Anatomy
- Profit in FY25 relied on deferred tax income; EBITDA margin was near zero.
- Online-only edge has eroded as many brands compete online.
- Revenue growth of 2.8x needs to be sustained.
- Valuation and primary versus secondary split of Series B not disclosed.
- Competition: low barriers to entry and large marketplaces make it hard for a brand to stay differentiated.
- Customer acquisition cost: paid marketing can become expensive and erode margins as a brand scales.
Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by consumer protection rules, FSSAI and BIS standards where relevant, the Legal Metrology rules and e-commerce regulations.
Bare Anatomy Growth Outlook: What to Watch
- Funds to go to product innovation, market expansion, scaling operations and team building.
- Key indicators: repeat purchase rate, average order value, gross margin, contribution margin and customer acquisition cost.
- Funding position: Whether Bare Anatomy can reach its next milestone before needing new capital.
- Regulation: Changes from consumer protection rules, FSSAI and BIS standards where relevant, the Legal Metrology rules and e-commerce regulations.
Industry Context: Where Bare Anatomy Fits
India's consumer market is large, young and increasingly online. Rising smartphone and internet use, digital payments and faster delivery have helped direct-to-consumer brands, marketplaces and quick-commerce platforms reach customers who once relied on local shops. Established companies, marketplaces and new brands now compete for the same shoppers.
Success in consumer businesses usually depends on a clear brand promise, repeat customers and healthy unit economics, not on sales volume alone. Companies that control quality, understand customer needs and manage marketing costs tend to build more durable brands than those that grow mainly by discounting.
For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.
Bull Case and Bear Case for Bare Anatomy
An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Bare Anatomy.
Bull case
- A growing base of online shoppers expands the potential market.
- Strong brands can earn repeat purchases and pricing power.
- Distribution through marketplaces, quick commerce and stores widens reach.
Bear case
- Heavy competition and discounting can hurt margins.
- Rising marketing costs can slow profitable growth.
- Supply-chain or quality problems can quickly damage trust.
Lessons Founders and Investors Can Take from Bare Anatomy
Studying a company in the Personalised haircare and skincare (D2C) space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Bare Anatomy.
- A clear brand identity and consistent product quality matter more than short-term sales spikes.
- Repeat customers lower acquisition costs and make growth more profitable.
- Controlling the supply chain helps protect quality and margins as volumes grow.
- Selling across several channels, such as own website, marketplaces, quick commerce and stores, reduces dependence on one platform.
- Healthy contribution margins are a better sign of progress than revenue growth alone.
How to Evaluate Bare Anatomy as a Startup
- Customer clarity: Can Bare Anatomy name its customer and the problem it solves in one sentence?
- Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
- Economics: Check whether margins improve as volume grows.
- Execution: Compare announced timelines with what has actually been delivered.
- Funding runway: Estimate how long current capital lasts at the present spending rate.
- Regulatory standing: Confirm required approvals are in place.
- Customer concentration: Check whether a few customers account for most of the revenue.
- Management depth: Look for experienced leaders beyond the founders and a stable core team.
The Takeaway
Bare Anatomy is part of India’s growing Personalised haircare and skincare (D2C) ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. Public sources can also describe the same company in different ways, so it is worth checking dates, definitions and whether a figure refers to revenue, total income or transaction value, and whether it covers one entity or a wider group, before drawing conclusions. Small differences in rounding, currency conversion or reporting periods can also change how a figure reads. Comparing the same figure across several recent reports helps show whether it is stable or has changed over time. This article is educational and is not investment advice.
- Clear customers and repeat demand matter more than announcements.
- Regulation and capital needs shape how fast a startup in this sector can grow.
- Track a few leading indicators over time rather than one headline metric.
Bare Anatomy FAQs: Frequently Asked Questions
What is Bare Anatomy?
Bare Anatomy is a Gurugram-based Indian personalised haircare and skincare brand, and a brand of parent company Innovist (formerly Onesto Labs); figures below for revenue and funding are the parent's. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.
Who founded Bare Anatomy?
Bare Anatomy was founded by Rohit Chawla, Sifat Khurana, Vimal Bhola, and the company reports a founding year of 2018.
How much funding has Bare Anatomy raised?
Over $16 million at Innovist level (before Series B reports differ). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.
How does Bare Anatomy make money?
Bare Anatomy earns revenue from its Personalised haircare and skincare (D2C) products and services sold to online shoppers, retail customers, marketplaces and distribution partners. The exact revenue mix is described in the business model section and is not fully disclosed publicly.
Who are the competitors of Bare Anatomy?
Reported rivals include Mamaearth, Minimalist, Desi Farms. See the competitor comparison above for how they differ.
What are the main risks for Bare Anatomy?
Main risks include competition: low barriers to entry and large marketplaces make it hard for a brand to stay differentiated, funding and capital needs, competition and regulation by consumer protection rules, FSSAI and BIS standards where relevant, the Legal Metrology rules and e-commerce regulations. This is educational content, not investment advice.
Related Startup Deep Dives: Prostocks — ProStocks: Sunlight Broking’s online discount broker, started 2016 | Deciml — Deciml: round-up investing app that raised $3M seed. Browse the full Startup Deep Dive series.
Source
Source: Publicly available data, published reports, industry research, and other credible sources.




